Acute Psychoses An Unusual Presentation of Empty.14
Acute Psychoses An Unusual Presentation of Empty.14
© 2019 CHRISMED Journal of Health and Research | Published by Wolters Kluwer - Medknow 187
Singhai, et al.: An unusual presentation of empty sella syndrome
blood glucose values were always below 100 mg/dl on treated with 50 mcg of thyroxine, prednisolone 5 mg in the
repeated measurements, serum creatinine 0.71 mg/dl morning, and 2.5 mg in the evening with fludrocortisone
(0.5–0.9), blood urea 17 mg/dl (20–40), serum sodium 0.1 mg once a day. Gradually, the patient’s general
116 mEq/L (136–145), serum potassium 3.58 mEq/L condition improved with the above treatment, serum
(3.5–5.1), serum chloride 87 mEq/L (98–107), serum sodium was corrected, and the patient was discharged after
bilirubin 0.63 mg/dl (0.3–1.2), alanine aminotransferase 8 days of hospitalization in stable condition.
52 IU/L (0–35), aspartate aminotransferase 99 IU/L (0–
35), alkaline phosphatase 83 IU/L (30–120), erythrocyte Discussion
sedimentation rate 10 mm (1–10), and serum albumin This case report highlights the importance of extensive
4.10 (3.5–5.5). Then, the patient was referred to physician workup in a case of hyponatremia. Panhypopituitarism is
in view of hyponatremia. The patient was treated with 3% a relatively rare disorder, with its incidence and prevalence
saline. being 4.2 per 100,000 per year and 45.5 per 100,000,
Further workup for hormone assays and radiological respectively.[1] Panhypopituitarism usually develops
investigation was planned and reports were as follows:
T3 0.22 ng/ml (0.6–1.81), T4 0.7 mcg/dl (4.5–10.9), free
T4 0.11 (0.89–1.77), thyroid‑stimulating hormone 2.85 mcg
U/ml (0.35–5.5), random serum cortisol 1.45 mcg/dl
(4.30–22.40), adrenocorticotropic hormone 14.50 pg/
ml (<46.00), and follicle‑stimulating hormone 12.41 mU/
ml (15.9–54). These investigations were suggestive of
panhypopituitarism. Table 1 shows the symptoms and
clinical signs that favor hypopituitarism. No significant
brain parenchymal abnormality was seen on noncontrast
computed tomography head. After this, magnetic resonance
imaging brain with contrast was planned, which showed
empty sella with a significantly reduced size of the anterior
pituitary gland (approximately 1.5‑mm thickness) with no
adenoma [Figure 1]. The posterior pituitary bright spot is
seen normal, the pituitary stalk is seen normal in position,
Figure 1: Magnetic resonance imaging brain showing empty sella with
and a tiny focus of microhemorrhage is noted involving significantly reduced size of anterior pituitary gland (approximately 1.5‑mm
right paraventricular region. Following this, the patient was thickness) with no adenoma
188 CHRISMED Journal of Health and Research | Volume 6 | Issue 3 | July-September 2019
Singhai, et al.: An unusual presentation of empty sella syndrome
gradually and insidiously; symptomatology is unspecific so Table 2: New class of drugs for hyponatremia
that diagnosis is often delayed.[2,3] Drug class Dosage Mechanism of action
There are two types of ESS which are as follows: primary Tolvaptan Oral Selective vasopressin 2
and secondary. Primary ESS happens when a small Lixivaptan receptor antagonists
anatomical defect above the pituitary gland increases (not FDA approved)
pressure in the sella turcica and causes the gland to flatten Satavaptan
(not FDA approved)
out along the interior walls of the sella turcica cavity.
Mozavaptan
Primary ESS is associated with obesity and an increase in
Conivaptan Given as IVNonselective V1 and V2
intracranial pressure in women.[8] In most cases, especially
infusion bocker, maximally blocks
in people with primary ESS, there are no symptoms and V2
it does not affect life expectancy. Some researchers have IV: Intravenous, FDA: Food and drug administration
estimated that less than 1% of affected people ever develop
symptoms of the condition. conditions such as panhypopituitarism.[3] The onset of
Secondary ESS is the result of the pituitary gland panhypopituitarism may be insidious and sometimes
regressing within the cavity after an injury, surgery, or with mild nonspecific symptoms. Symptoms such as loss
radiation therapy. Individuals with secondary ESS due to of energy, fatigue, and decreased libido are common in
the destruction of the pituitary gland have symptoms that the elderly, thus physicians often fail in misdiagnosis
reflect the loss of pituitary functions such as intolerance to and consider hyponatremia as a normal consequence of
stress and infection. aging.[1,3] Table 2 shows the new class of drugs available
for the treatment of hyponatremia.
Stable patients who are diagnosed with panhypopituitarism
have a favorable prognosis with replacement hormone Conclusion
therapy; however, patients with acute decompensation are
in critical condition and may have a high mortality rate. ESS is a rare disease, and most of the time it left
Four retrospective studies from the United Kingdom and undiagnosed, and patients with panhypopituitarism are
Sweden showed that mortality is increased by 1.3–2.2 at high mortality risk; hence, hormone assays should be
fold in patients with panhypopituitarism, compared with included in the initial diagnostic workup of hyponatremia.
age‑ and sex‑matched cohorts.[9] Morbidity is variable and Declaration of patient consent
may depend on hormone deficiency, underlying disease, or
inadequate long‑term replacement therapy. The authors certify that they have obtained all appropriate
patient consent forms. In the form the patient(s) has/have
Recent studies have shown that people with a previous given his/her/their consent for his/her/their images and
traumatic brain injury, spontaneous subarachnoid other clinical information to be reported in the journal. The
hemorrhage (a type of stroke), or radiation therapy involving patients understand that their names and initials will not
the head have a higher risk of panhypopituitarism.[10] be published and due efforts will be made to conceal their
After traumatic brain injury, as much as a quarter have identity, but anonymity cannot be guaranteed.
persistent pituitary hormone deficiencies.[11] Many of these
people may have subtle or nonspecific symptoms that are Financial support and sponsorship
not linked to pituitary problems but are attributed to their Nil.
previous condition. Hence, it is possible that many cases
of panhypopituitarism remain undiagnosed, and the annual Conflicts of interest
incidence would rise to 31 per 100,000 annually if the There are no conflicts of interest.
people are from these risk groups were to be tested.[4]
References
The term hyponatremia is defined as a serum sodium
concentration <136 mEq/L. It is a common electrolyte 1. Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet
2016;388:2403‑15.
abnormality in the general population and also in hospitalized
2. Curtò L, Trimarchi F. Hypopituitarism in the elderly:
patients.[6,12] Patients who present with mild‑to‑moderate
A narrative review on clinical management of
forms of hyponatremia (126‑135 mEq/L) may be hypothalamic‑pituitary‑gonadal, hypothalamic‑pituitary‑thyroid
asymptomatic and are often overlooked. A careful history, and hypothalamic‑pituitary‑adrenal axes dysfunction.
including pharmacological history and physical examination, J Endocrinol Invest 2016;39:1115‑24.
often provides useful clues to the underlying cause. 3. Wakil A, Ng JM, Atkin SL. Investigating hyponatraemia. BMJ
2011;342:d1118.
Thiazide diuretics and the syndrome of inappropriate 4. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH,
antidiuretic hormone secretion are the most common Hoorn EJ, et al. Electrolyte disorders in community subjects:
causes of hyponatremia encountered in clinical practice.[3‑12] Prevalence and risk factors. Am J Med 2013;126:256‑63.
Hyponatremia could be an early sign of severe medical 5. Drake‑Holland AJ, Noble MI. The hyponatremia epidemic:
CHRISMED Journal of Health and Research | Volume 6 | Issue 3 | July-September 2019 189
Singhai, et al.: An unusual presentation of empty sella syndrome
A frontier too far? Front Cardiovasc Med 2016;3:35. hypopituitarism. Growth Horm IGF Res 1998;8 Suppl A: 69‑76.
6. Giordano M, Ciarambino T, Castellino P, Malatino L, 10. Schneider HJ, Kreitschmann‑Andermahr I, Ghigo E, Stalla GK,
Di Somma S, Biolo G, et al. Diseases associated with electrolyte Agha A. Hypothalamopituitary dysfunction following traumatic
imbalance in the ED: Age‑related differences. Am J Emerg Med brain injury and aneurysmal subarachnoid hemorrhage:
2016;34:1923‑6. A systematic review. JAMA 2007;298:1429‑38.
7. Catalano A, Basile G, Lasco A. Hypocalcemia: A sometimes 11. Behan LA, Phillips J, Thompson CJ, Agha A. Neuroendocrine
overlooked cause of heart failure in the elderly. Aging Clin Exp disorders after traumatic brain injury. J Neurol Neurosurg
Res 2012;24:400‑3. Psychiatry 2008;79:753‑9.
8. Wael F. Review of empty sella syndrome and its surgical 12. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact
management. Alex J Med 2011;47:139‑47. of hospital‑associated hyponatremia on selected outcomes. Arch
9. Clayton RN. Mortality, cardiovascular events and risk factors in Intern Med 2010;170:294‑302.
190 CHRISMED Journal of Health and Research | Volume 6 | Issue 3 | July-September 2019